Replies to post #11426 on Mast Therapeutics, Inc. (MSTX)

[Ecomike]

Keep in mind folks, that MSTX bought this drug off the shelf from CYTR, because CYTR had too many irons in the fire and too little money at the time, about 2 years ago. I know because I bought CYTR at about 30 cents in 2009 and it recently hit about $8, and it hit a massive market cap I never expected to see, as did KERX late last year. It is MSTX 's turn now.